世界の呼吸器吸入器市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Respiratory Inhalers Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z5006 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、呼吸器吸入器のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ドライパウダー吸入器、定量吸入器、その他）、用途別市場規模（喘息、慢性閉塞性肺疾患、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・呼吸器吸入器の市場動向 ・企業の競争状況、市場シェア ・呼吸器吸入器の種類別市場規模（ドライパウダー吸入器、定量吸入器、その他） ・呼吸器吸入器の用途別市場規模（喘息、慢性閉塞性肺疾患、その他） ・呼吸器吸入器の北米市場規模2016-2027（アメリカ、カナダ） ・呼吸器吸入器のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・呼吸器吸入器のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・呼吸器吸入器の中南米市場規模2016-2027（メキシコ、ブラジル） ・呼吸器吸入器の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Adherium limited、AstraZeneca、Boehringer Ingelheim GmbH、Chiesi Farmaceutici S.p.A.、GSK plc.、Propeller Health、Teva Pharmaceutical Industries Ltd.） ・結論

Respiratory disorders have always been a huge challenge for the drug manufacturers and the medical practitioners. In the last couple of decades, this respiratory disorder prevalence has increased tremendously due to some of the reasons such as air pollution, smoking, industrialization among others. To counter these respiratory disorders, scientists have developed various drugs and devices. Extensive efforts have been made to control the disorders such as Asthma and Chronic obstructive pulmonary disorder which affects the majority of the patients.
Globally North America is the largest market for Respiratory Inhalers accounting 35.1% of the total market. This large share is majorly due to, tobacco smoke which is a key factor in the development and progression of COPD. COPD was considered the third leading cause of death in U.S. in 2017, with almost 6% of Americans diagnosed with the disease.

Market Analysis and Insights: Global Respiratory Inhalers Market
The global Respiratory Inhalers market size is projected to reach US$ 31670 million by 2026, from US$ 28800 million in 2019, at a CAGR of 1.3% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Respiratory Inhalers market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Respiratory Inhalers market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Respiratory Inhalers market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Respiratory Inhalers market.

Global Respiratory Inhalers Scope and Market Size
Respiratory Inhalers market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Respiratory Inhalers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Dry Powder Inhaler
Metered Dose Inhaler
Others

Segment by Application
Asthma
COPD
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Adherium limited
AstraZeneca
Boehringer Ingelheim GmbH
Chiesi Farmaceutici S.p.A.
GSK plc.
Propeller Health
Teva Pharmaceutical Industries Ltd.

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Respiratory Inhalers Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Dry Powder Inhaler
1.2.3 Metered Dose Inhaler
1.2.4 Others
1.3 Market by Application
1.3.1 Global Respiratory Inhalers Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Asthma
1.3.3 COPD
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Respiratory Inhalers Market Perspective (2016-2027)
2.2 Respiratory Inhalers Growth Trends by Regions
2.2.1 Respiratory Inhalers Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Respiratory Inhalers Historic Market Share by Regions (2016-2021)
2.2.3 Respiratory Inhalers Forecasted Market Size by Regions (2022-2027)
2.3 Respiratory Inhalers Industry Dynamic
2.3.1 Respiratory Inhalers Market Trends
2.3.2 Respiratory Inhalers Market Drivers
2.3.3 Respiratory Inhalers Market Challenges
2.3.4 Respiratory Inhalers Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Respiratory Inhalers Players by Revenue
3.1.1 Global Top Respiratory Inhalers Players by Revenue (2016-2021)
3.1.2 Global Respiratory Inhalers Revenue Market Share by Players (2016-2021)
3.2 Global Respiratory Inhalers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Respiratory Inhalers Revenue
3.4 Global Respiratory Inhalers Market Concentration Ratio
3.4.1 Global Respiratory Inhalers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Respiratory Inhalers Revenue in 2020
3.5 Respiratory Inhalers Key Players Head office and Area Served
3.6 Key Players Respiratory Inhalers Product Solution and Service
3.7 Date of Enter into Respiratory Inhalers Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Respiratory Inhalers Breakdown Data by Type
4.1 Global Respiratory Inhalers Historic Market Size by Type (2016-2021)
4.2 Global Respiratory Inhalers Forecasted Market Size by Type (2022-2027)

5 Respiratory Inhalers Breakdown Data by Application
5.1 Global Respiratory Inhalers Historic Market Size by Application (2016-2021)
5.2 Global Respiratory Inhalers Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Respiratory Inhalers Market Size (2016-2027)
6.2 North America Respiratory Inhalers Market Size by Type
6.2.1 North America Respiratory Inhalers Market Size by Type (2016-2021)
6.2.2 North America Respiratory Inhalers Market Size by Type (2022-2027)
6.2.3 North America Respiratory Inhalers Market Size by Type (2016-2027)
6.3 North America Respiratory Inhalers Market Size by Application
6.3.1 North America Respiratory Inhalers Market Size by Application (2016-2021)
6.3.2 North America Respiratory Inhalers Market Size by Application (2022-2027)
6.3.3 North America Respiratory Inhalers Market Size by Application (2016-2027)
6.4 North America Respiratory Inhalers Market Size by Country
6.4.1 North America Respiratory Inhalers Market Size by Country (2016-2021)
6.4.2 North America Respiratory Inhalers Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Respiratory Inhalers Market Size (2016-2027)
7.2 Europe Respiratory Inhalers Market Size by Type
7.2.1 Europe Respiratory Inhalers Market Size by Type (2016-2021)
7.2.2 Europe Respiratory Inhalers Market Size by Type (2022-2027)
7.2.3 Europe Respiratory Inhalers Market Size by Type (2016-2027)
7.3 Europe Respiratory Inhalers Market Size by Application
7.3.1 Europe Respiratory Inhalers Market Size by Application (2016-2021)
7.3.2 Europe Respiratory Inhalers Market Size by Application (2022-2027)
7.3.3 Europe Respiratory Inhalers Market Size by Application (2016-2027)
7.4 Europe Respiratory Inhalers Market Size by Country
7.4.1 Europe Respiratory Inhalers Market Size by Country (2016-2021)
7.4.2 Europe Respiratory Inhalers Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Respiratory Inhalers Market Size (2016-2027)
8.2 Asia-Pacific Respiratory Inhalers Market Size by Type
8.2.1 Asia-Pacific Respiratory Inhalers Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Respiratory Inhalers Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Respiratory Inhalers Market Size by Type (2016-2027)
8.3 Asia-Pacific Respiratory Inhalers Market Size by Application
8.3.1 Asia-Pacific Respiratory Inhalers Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Respiratory Inhalers Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Respiratory Inhalers Market Size by Application (2016-2027)
8.4 Asia-Pacific Respiratory Inhalers Market Size by Region
8.4.1 Asia-Pacific Respiratory Inhalers Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Respiratory Inhalers Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Respiratory Inhalers Market Size (2016-2027)
9.2 Latin America Respiratory Inhalers Market Size by Type
9.2.1 Latin America Respiratory Inhalers Market Size by Type (2016-2021)
9.2.2 Latin America Respiratory Inhalers Market Size by Type (2022-2027)
9.2.3 Latin America Respiratory Inhalers Market Size by Type (2016-2027)
9.3 Latin America Respiratory Inhalers Market Size by Application
9.3.1 Latin America Respiratory Inhalers Market Size by Application (2016-2021)
9.3.2 Latin America Respiratory Inhalers Market Size by Application (2022-2027)
9.3.3 Latin America Respiratory Inhalers Market Size by Application (2016-2027)
9.4 Latin America Respiratory Inhalers Market Size by Country
9.4.1 Latin America Respiratory Inhalers Market Size by Country (2016-2021)
9.4.2 Latin America Respiratory Inhalers Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Respiratory Inhalers Market Size (2016-2027)
10.2 Middle East & Africa Respiratory Inhalers Market Size by Type
10.2.1 Middle East & Africa Respiratory Inhalers Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Respiratory Inhalers Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Respiratory Inhalers Market Size by Type (2016-2027)
10.3 Middle East & Africa Respiratory Inhalers Market Size by Application
10.3.1 Middle East & Africa Respiratory Inhalers Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Respiratory Inhalers Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Respiratory Inhalers Market Size by Application (2016-2027)
10.4 Middle East & Africa Respiratory Inhalers Market Size by Country
10.4.1 Middle East & Africa Respiratory Inhalers Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Respiratory Inhalers Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Adherium limited
11.1.1 Adherium limited Company Details
11.1.2 Adherium limited Business Overview
11.1.3 Adherium limited Respiratory Inhalers Introduction
11.1.4 Adherium limited Revenue in Respiratory Inhalers Business (2016-2021)
11.1.5 Adherium limited Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Respiratory Inhalers Introduction
11.2.4 AstraZeneca Revenue in Respiratory Inhalers Business (2016-2021)
11.2.5 AstraZeneca Recent Development
11.3 Boehringer Ingelheim GmbH
11.3.1 Boehringer Ingelheim GmbH Company Details
11.3.2 Boehringer Ingelheim GmbH Business Overview
11.3.3 Boehringer Ingelheim GmbH Respiratory Inhalers Introduction
11.3.4 Boehringer Ingelheim GmbH Revenue in Respiratory Inhalers Business (2016-2021)
11.3.5 Boehringer Ingelheim GmbH Recent Development
11.4 Chiesi Farmaceutici S.p.A.
11.4.1 Chiesi Farmaceutici S.p.A. Company Details
11.4.2 Chiesi Farmaceutici S.p.A. Business Overview
11.4.3 Chiesi Farmaceutici S.p.A. Respiratory Inhalers Introduction
11.4.4 Chiesi Farmaceutici S.p.A. Revenue in Respiratory Inhalers Business (2016-2021)
11.4.5 Chiesi Farmaceutici S.p.A. Recent Development
11.5 GSK plc.
11.5.1 GSK plc. Company Details
11.5.2 GSK plc. Business Overview
11.5.3 GSK plc. Respiratory Inhalers Introduction
11.5.4 GSK plc. Revenue in Respiratory Inhalers Business (2016-2021)
11.5.5 GSK plc. Recent Development
11.6 Propeller Health
11.6.1 Propeller Health Company Details
11.6.2 Propeller Health Business Overview
11.6.3 Propeller Health Respiratory Inhalers Introduction
11.6.4 Propeller Health Revenue in Respiratory Inhalers Business (2016-2021)
11.6.5 Propeller Health Recent Development
11.7 Teva Pharmaceutical Industries Ltd.
11.7.1 Teva Pharmaceutical Industries Ltd. Company Details
11.7.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.7.3 Teva Pharmaceutical Industries Ltd. Respiratory Inhalers Introduction
11.7.4 Teva Pharmaceutical Industries Ltd. Revenue in Respiratory Inhalers Business (2016-2021)
11.7.5 Teva Pharmaceutical Industries Ltd. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Respiratory Inhalers Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Dry Powder Inhaler
Table 3. Key Players of Metered Dose Inhaler
Table 4. Key Players of Others
Table 5. Global Respiratory Inhalers Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Respiratory Inhalers Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Respiratory Inhalers Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Respiratory Inhalers Market Share by Regions (2016-2021)
Table 9. Global Respiratory Inhalers Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Respiratory Inhalers Market Share by Regions (2022-2027)
Table 11. Respiratory Inhalers Market Trends
Table 12. Respiratory Inhalers Market Drivers
Table 13. Respiratory Inhalers Market Challenges
Table 14. Respiratory Inhalers Market Restraints
Table 15. Global Respiratory Inhalers Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Respiratory Inhalers Market Share by Players (2016-2021)
Table 17. Global Top Respiratory Inhalers Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Respiratory Inhalers as of 2020)
Table 18. Ranking of Global Top Respiratory Inhalers Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Respiratory Inhalers Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Respiratory Inhalers Product Solution and Service
Table 22. Date of Enter into Respiratory Inhalers Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Respiratory Inhalers Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Respiratory Inhalers Revenue Market Share by Type (2016-2021)
Table 26. Global Respiratory Inhalers Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Respiratory Inhalers Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Respiratory Inhalers Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Respiratory Inhalers Revenue Market Share by Application (2016-2021)
Table 30. Global Respiratory Inhalers Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Respiratory Inhalers Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Respiratory Inhalers Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Respiratory Inhalers Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Respiratory Inhalers Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Respiratory Inhalers Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Respiratory Inhalers Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Respiratory Inhalers Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Respiratory Inhalers Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Respiratory Inhalers Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Respiratory Inhalers Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Respiratory Inhalers Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Respiratory Inhalers Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Respiratory Inhalers Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Respiratory Inhalers Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Respiratory Inhalers Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Respiratory Inhalers Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Respiratory Inhalers Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Respiratory Inhalers Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Respiratory Inhalers Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Respiratory Inhalers Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Respiratory Inhalers Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Respiratory Inhalers Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Respiratory Inhalers Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Respiratory Inhalers Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Respiratory Inhalers Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Respiratory Inhalers Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Respiratory Inhalers Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Respiratory Inhalers Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Respiratory Inhalers Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Respiratory Inhalers Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Respiratory Inhalers Market Size by Country (2022-2027) & (US$ Million)
Table 62. Adherium limited Company Details
Table 63. Adherium limited Business Overview
Table 64. Adherium limited Respiratory Inhalers Product
Table 65. Adherium limited Revenue in Respiratory Inhalers Business (2016-2021) & (US$ Million)
Table 66. Adherium limited Recent Development
Table 67. AstraZeneca Company Details
Table 68. AstraZeneca Business Overview
Table 69. AstraZeneca Respiratory Inhalers Product
Table 70. AstraZeneca Revenue in Respiratory Inhalers Business (2016-2021) & (US$ Million)
Table 71. AstraZeneca Recent Development
Table 72. Boehringer Ingelheim GmbH Company Details
Table 73. Boehringer Ingelheim GmbH Business Overview
Table 74. Boehringer Ingelheim GmbH Respiratory Inhalers Product
Table 75. Boehringer Ingelheim GmbH Revenue in Respiratory Inhalers Business (2016-2021) & (US$ Million)
Table 76. Boehringer Ingelheim GmbH Recent Development
Table 77. Chiesi Farmaceutici S.p.A. Company Details
Table 78. Chiesi Farmaceutici S.p.A. Business Overview
Table 79. Chiesi Farmaceutici S.p.A. Respiratory Inhalers Product
Table 80. Chiesi Farmaceutici S.p.A. Revenue in Respiratory Inhalers Business (2016-2021) & (US$ Million)
Table 81. Chiesi Farmaceutici S.p.A. Recent Development
Table 82. GSK plc. Company Details
Table 83. GSK plc. Business Overview
Table 84. GSK plc. Respiratory Inhalers Product
Table 85. GSK plc. Revenue in Respiratory Inhalers Business (2016-2021) & (US$ Million)
Table 86. GSK plc. Recent Development
Table 87. Propeller Health Company Details
Table 88. Propeller Health Business Overview
Table 89. Propeller Health Respiratory Inhalers Product
Table 90. Propeller Health Revenue in Respiratory Inhalers Business (2016-2021) & (US$ Million)
Table 91. Propeller Health Recent Development
Table 92. Teva Pharmaceutical Industries Ltd. Company Details
Table 93. Teva Pharmaceutical Industries Ltd. Business Overview
Table 94. Teva Pharmaceutical Industries Ltd. Respiratory Inhalers Product
Table 95. Teva Pharmaceutical Industries Ltd. Revenue in Respiratory Inhalers Business (2016-2021) & (US$ Million)
Table 96. Teva Pharmaceutical Industries Ltd. Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Respiratory Inhalers Market Share by Type: 2020 VS 2027
Figure 2. Dry Powder Inhaler Features
Figure 3. Metered Dose Inhaler Features
Figure 4. Others Features
Figure 5. Global Respiratory Inhalers Market Share by Application: 2020 VS 2027
Figure 6. Asthma Case Studies
Figure 7. COPD Case Studies
Figure 8. Other Case Studies
Figure 9. Respiratory Inhalers Report Years Considered
Figure 10. Global Respiratory Inhalers Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Respiratory Inhalers Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Respiratory Inhalers Market Share by Regions: 2020 VS 2027
Figure 13. Global Respiratory Inhalers Market Share by Regions (2022-2027)
Figure 14. Global Respiratory Inhalers Market Share by Players in 2020
Figure 15. Global Top Respiratory Inhalers Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Respiratory Inhalers as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Respiratory Inhalers Revenue in 2020
Figure 17. Global Respiratory Inhalers Revenue Market Share by Type (2016-2021)
Figure 18. Global Respiratory Inhalers Revenue Market Share by Type (2022-2027)
Figure 19. North America Respiratory Inhalers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Respiratory Inhalers Market Share by Type (2016-2027)
Figure 21. North America Respiratory Inhalers Market Share by Application (2016-2027)
Figure 22. North America Respiratory Inhalers Market Share by Country (2016-2027)
Figure 23. United States Respiratory Inhalers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Respiratory Inhalers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Respiratory Inhalers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Respiratory Inhalers Market Share by Type (2016-2027)
Figure 27. Europe Respiratory Inhalers Market Share by Application (2016-2027)
Figure 28. Europe Respiratory Inhalers Market Share by Country (2016-2027)
Figure 29. Germany Respiratory Inhalers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Respiratory Inhalers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Respiratory Inhalers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Respiratory Inhalers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Respiratory Inhalers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Respiratory Inhalers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Respiratory Inhalers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Respiratory Inhalers Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Respiratory Inhalers Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Respiratory Inhalers Market Share by Region (2016-2027)
Figure 39. China Respiratory Inhalers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Respiratory Inhalers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Respiratory Inhalers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Respiratory Inhalers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Respiratory Inhalers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Respiratory Inhalers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Respiratory Inhalers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Respiratory Inhalers Market Share by Type (2016-2027)
Figure 47. Latin America Respiratory Inhalers Market Share by Application (2016-2027)
Figure 48. Latin America Respiratory Inhalers Market Share by Country (2016-2027)
Figure 49. Mexico Respiratory Inhalers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Respiratory Inhalers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Respiratory Inhalers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Respiratory Inhalers Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Respiratory Inhalers Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Respiratory Inhalers Market Share by Country (2016-2027)
Figure 55. Turkey Respiratory Inhalers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Respiratory Inhalers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Respiratory Inhalers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Adherium limited Revenue Growth Rate in Respiratory Inhalers Business (2016-2021)
Figure 59. AstraZeneca Revenue Growth Rate in Respiratory Inhalers Business (2016-2021)
Figure 60. Boehringer Ingelheim GmbH Revenue Growth Rate in Respiratory Inhalers Business (2016-2021)
Figure 61. Chiesi Farmaceutici S.p.A. Revenue Growth Rate in Respiratory Inhalers Business (2016-2021)
Figure 62. GSK plc. Revenue Growth Rate in Respiratory Inhalers Business (2016-2021)
Figure 63. Propeller Health Revenue Growth Rate in Respiratory Inhalers Business (2016-2021)
Figure 64. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Respiratory Inhalers Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

---